secwatch / observer
8-K filed May 8, 2023, 7:59 PM ET ticker ESTA CIK 0001688757
earnings confidence high sentiment neutral materiality 0.70

Establishment Labs Q1 revenue $46.5M (+21% YoY), net loss widens to $11.9M

ESTABLISHMENT LABS HOLDINGS INC.

2023-Q1 EPS reported -$0.48 revenue$46,524,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

ESTABLISHMENT LABS HOLDINGS INC. reported the first quarter ended March 31, 2023 results: revenue $46.5 million, net income $11.9 million. Guidance reaffirmed.

Period
the first quarter ended March 31, 2023
Revenue
$46.5 million
Net income
$11.9 million
Guidance
reaffirmed
Result
reported results
Exact text from the filing
Establishment Labs Reports Record First Quarter 2023 Financial Results NEW YORK, NY, May 8, 2023 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the first quarter ended March 31, 2023. First Quarter Highlights and Outlook • First quarter worldwide revenue of $46.5 million increased 21.0% year-over-year and was a new quarterly record; excluding the impact of foreign currency changes, revenue growth in the first quarter would have been 22.9%. • 2023 revenue guidance remains $200 million to $210 million, an increase of 24% to 30% over 2022. • First quarter loss from operations was $8.2 million compared to a loss of $5.6 million in the year-ago period as investment in growth initiatives increased. • Cash balance of $42.8 million as of March 31, 2023. • Completed follow-on share offering on April 27, with gross
View on SEC.gov

Browse all earnings releases →

ESTABLISHMENT LABS HOLDINGS INC. filing history →

Source: SEC EDGAR
accession 0001688757-23-000053
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.